Fundraising FoxBenitec Biopharma
Hayward, US · Founded 2019 · Delaware corporation
Find your way into Benitec Biopharma
Each arrow is one introduction. Sign up to fill in the first one.
343 people can intro you to Megan
Ask Sakura Holloway to introduce you to Megan Boston
You →Sakura · together at Benitec Biopharma →Megan
3 people can intro you to Jerel
Ask Jamie Chen to introduce you to Jerel Banks
You →Jamie · together at Benitec Biopharma →Jerel
Sign up to find every way you can get introduced to Benitec Biopharma
- Your email: who you already know at Benitec Biopharma, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Benitec Biopharma team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Benitec Biopharma is a clinical-stage biotechnology company developing genetic medicines using its ddRNAi platform, which combines RNA interference with gene therapy to silence disease-causing genes through a single administration. It develops therapeutics for chronic and life-threatening conditions, including Oculopharyngeal Muscular Dystrophy (OPMD).
Founders & leadership
JB
Jerel BanksChief Executive Officer & Chairman of the BoardJerel Banks is an M.D. and Ph.D. who has held executive leadership positions in biotechnology, serving as Director of Benitec Biopharma since 2016, Chairman since 2017, and CEO since 2018. He brings decades of experience in biotechnology research and portfolio management to lead the company's development of ddRNAi-based therapeutics.
MB
Megan BostonExecutiveMegan Boston is a Chartered Accountant with over 25 years of experience in financial management across biotech, technology, and financial services firms, and more than 20 years of non-executive board service with public and private companies.
PF
Peter FrancisNamed on SEC filing
ES
Board
JK
J. Kevin BuchiBoard director
Reported raises · per SEC filings
Form D private placements$40M disclosed across 1 of 2 rounds · 2024–2026
▶$40MraisedApr 2024 · 17 investors · BiotechnologyRule 506(b)
▶$40MraisedApr 2024 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- J. Kevin BuchiDirector
- Peter FrancisDirector
- Edward SmithDirector
- Jerel BanksExecutive Officer, Director
- Megan BostonExecutive Officer, Director
- Offering amount
- $40M
- Amount sold
- $40M
- Sales commissions
- $2.4M
- Placement agents
- Leerink Partners LLC, Citizens JMP Securities, LLC
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 7
Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
RobinhoodRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
NasdaqNasdaq operates a technology infrastructure platform for financial markets across three business segments: Capital Access Platforms (which includes listing services, indices, and analytics tools), Financial Technology (comprising compliance, regulatory, and capital markets software), and Market Services (equities and derivatives trading operations). The company serves financial institutions, listed companies, investment managers, and regulatory agencies globally.
Simply Wall StSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
TradingViewTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
StockTwitsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
KrakenKraken 360 Investments provides capital and launch infrastructure to blockchain protocols in pre-token and early post-token phases, offering custody, staking, treasury, and liquidity services alongside fundraising support.
Companies working in the same space as Benitec Biopharma.
Frequently asked questions
- What does Benitec Biopharma do?
- Benitec Biopharma is a clinical-stage biotechnology company developing genetic medicines using its ddRNAi platform, which combines RNA interference with gene therapy to silence disease-causing genes through a single administration. It develops therapeutics for chronic and life-threatening conditions, including Oculopharyngeal Muscular Dystrophy (OPMD).
- How much funding has Benitec Biopharma raised?
- Benitec Biopharma has disclosed $40M raised across 1 of its 2 known rounds.
- Where is Benitec Biopharma headquartered?
- Benitec Biopharma is headquartered in Hayward, US.